Axel Grothey, MD, Consultant, West Cancer Center, University of Tennessee, Discusses The Use Of Regorafenib In The Management Of Advanced CRC. At The 2019 Gastrointestinal Cancers Symposium In San Francisco, CA On Jan 17, 2019. http://obroncology.com
